Shaimaa Ahmadeen
Scientific evaluation expert Saudi FDA
Seminars
Wednesday 19th August 2026
Harnessing Sequencing for Digital QC & Impurity Intelligence to Build Actionable & Reproducible Oligonucleotide Manufacturing Control Strategies
1:30 pm
- Identifying sequence-related variants that influence batch consistency and downstream complexity to better inform manufacturing control strategies
- Apply high-resolution variant profiling to anticipate impurity shifts during scale-up and tech transfer, to enable more predictable manufacturing
- Integrating sequencing data into comparability assessments to strengthen regulatory confidence across the product lifecycle
